Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Performance
The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The business’s 50 day moving average is C$2.00 and its 200 day moving average is C$2.00. The stock has a market capitalization of C$21.54 million and a PE ratio of -12.66.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
- Five stocks we like better than Liberty Biopharma
- Stock Market Upgrades: What Are They?
- Does UPS stock going down present an opportunity?
- Earnings Per Share Calculator: How to Calculate EPS
- The truth behind Williams-Sonoma stock drop
- There Are Different Types of Stock To Invest In
- Is Airbnb a buy on fee increase, international growth?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.